We are analyzing https://link.springer.com/article/10.1007/s11306-024-02142-x.

Title:
Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform | Metabolomics
Description:
Background The multitude of metabolites generated by physiological processes in the body can serve as valuable biomarkers for many clinical purposes. They can provide a window into relevant metabolic pathways for health and disease, as well as be candidate therapeutic targets. A subset of these metabolites generated in the human body are volatile, known as volatile organic compounds (VOCs), which can be detected in exhaled breath. These can diffuse from their point of origin throughout the body into the bloodstream and exchange into the air in the lungs. For this reason, breath VOC analysis has become a focus of biomedical research hoping to translate new useful biomarkers by taking advantage of the non-invasive nature of breath sampling, as well as the rapid rate of collection over short periods of time that can occur. Despite the promise of breath analysis as an additional platform for metabolomic analysis, no VOC breath biomarkers have successfully been implemented into a clinical setting as of the time of this review. Aim of review This review aims to summarize the progress made to address the major methodological challenges, including standardization, that have historically limited the translation of breath VOC biomarkers into the clinic. We highlight what steps can be taken to improve these issues within new and ongoing breath research to promote the successful development of the VOCs in breath as a robust source of candidate biomarkers. We also highlight key recent papers across select fields, critically reviewing the progress made in the past few years to advance breath research. Key scientific concepts of review VOCs are a set of metabolites that can be sampled in exhaled breath to act as advantageous biomarkers in a variety of clinical contexts.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

breath, article, pubmed, google, scholar, vocs, cas, analysis, study, cancer, exhaled, voc, volatile, biomarkers, journal, compounds, van, patients, research, disease, clinical, central, organic, lung, diseases, liver, asthma, respiratory, sampling, potential, httpsdoiorg, collection, studies, controls, review, human, recent, diagnosis, metabolites, infection, air, children, biomarker, detection, medicine, including, specific, healthy, identified, test,

Topics {✒️}

fiber-derivatisation spme–gc/ms gas chromatography-mass spectrometry needle trap device-gc-ms article download pdf low-molecular-weight volatile metabolites needle trap-gc-ms short-chain fatty acids proton-transfer-reaction time multidimensional gas chromatography—time e-nose technology operates minimize inter-individual variation diabetes mellitus diagnosis maitland-van der zee virus-induced breath biomarkers 13c-urea breath test including anti-inflammatory action monitoring drug pharmacokinetics/pharmacodynamics early-onset asthma reveal determine breath-bourne vocs flight mass spectrometry flight mass spectrometry real-time breath analysis virus-infected healthy volunteers overnight-fasted cirrhotic patients cancer-specific voc profiles portable e-nose approach van der sar breath-based biomarker discovery real-life clinical settings fernández del río combining exhaled-breath data early-stage liver diseases irritable bowel syndrome van den velde inclusion/exclusion patient criteria plant-originating compound increased end-stage liver disease metabolic pathway-specific probes intestinal methanogen overgrowth viral-specific voc pattern bio-voc™ breath sampler privacy choices/manage cookies voc 2-pentyl furan van der kamp detecting liver-related vocs volatile organic compounds thermal desorption tubes perioperative breathomics testing dimensional gas chromatography portable gas chromatography

Questions {❓}

Breath analysis by mass spectrometry: A new tool for breast cancer detection?
Can exhaled volatile organic compounds predict asthma exacerbations in children?
The use of breath analysis in the management of lung cancer: is it ready for primetime?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform
         description:The multitude of metabolites generated by physiological processes in the body can serve as valuable biomarkers for many clinical purposes. They can provide a window into relevant metabolic pathways for health and disease, as well as be candidate therapeutic targets. A subset of these metabolites generated in the human body are volatile, known as volatile organic compounds (VOCs), which can be detected in exhaled breath. These can diffuse from their point of origin throughout the body into the bloodstream and exchange into the air in the lungs. For this reason, breath VOC analysis has become a focus of biomedical research hoping to translate new useful biomarkers by taking advantage of the non-invasive nature of breath sampling, as well as the rapid rate of collection over short periods of time that can occur. Despite the promise of breath analysis as an additional platform for metabolomic analysis, no VOC breath biomarkers have successfully been implemented into a clinical setting as of the time of this review. This review aims to summarize the progress made to address the major methodological challenges, including standardization, that have historically limited the translation of breath VOC biomarkers into the clinic. We highlight what steps can be taken to improve these issues within new and ongoing breath research to promote the successful development of the VOCs in breath as a robust source of candidate biomarkers. We also highlight key recent papers across select fields, critically reviewing the progress made in the past few years to advance breath research. VOCs are a set of metabolites that can be sampled in exhaled breath to act as advantageous biomarkers in a variety of clinical contexts.
         datePublished:2024-07-08T00:00:00Z
         dateModified:2024-07-08T00:00:00Z
         pageStart:1
         pageEnd:25
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s11306-024-02142-x
         keywords:
            Breath analysis
            Volatile organic compounds
            Breath biomarkers
            Breathomics
            Volatilomics
            Biochemistry
            general
            Molecular Medicine
            Cell Biology
            Developmental Biology
            Biomedicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig7_HTML.png
         isPartOf:
            name:Metabolomics
            issn:
               1573-3890
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hsuan Chou
               url:http://orcid.org/0000-0002-8028-225X
               affiliation:
                     name:Owlstone Medical Ltd.
                     address:
                        name:Owlstone Medical Ltd., Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lucy Godbeer
               affiliation:
                     name:Owlstone Medical Ltd.
                     address:
                        name:Owlstone Medical Ltd., Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Max Allsworth
               affiliation:
                     name:Owlstone Medical Ltd.
                     address:
                        name:Owlstone Medical Ltd., Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Billy Boyle
               affiliation:
                     name:Owlstone Medical Ltd.
                     address:
                        name:Owlstone Medical Ltd., Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Madeleine L. Ball
               url:http://orcid.org/0000-0002-6150-0485
               affiliation:
                     name:Owlstone Medical Ltd.
                     address:
                        name:Owlstone Medical Ltd., Cambridge, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform
      description:The multitude of metabolites generated by physiological processes in the body can serve as valuable biomarkers for many clinical purposes. They can provide a window into relevant metabolic pathways for health and disease, as well as be candidate therapeutic targets. A subset of these metabolites generated in the human body are volatile, known as volatile organic compounds (VOCs), which can be detected in exhaled breath. These can diffuse from their point of origin throughout the body into the bloodstream and exchange into the air in the lungs. For this reason, breath VOC analysis has become a focus of biomedical research hoping to translate new useful biomarkers by taking advantage of the non-invasive nature of breath sampling, as well as the rapid rate of collection over short periods of time that can occur. Despite the promise of breath analysis as an additional platform for metabolomic analysis, no VOC breath biomarkers have successfully been implemented into a clinical setting as of the time of this review. This review aims to summarize the progress made to address the major methodological challenges, including standardization, that have historically limited the translation of breath VOC biomarkers into the clinic. We highlight what steps can be taken to improve these issues within new and ongoing breath research to promote the successful development of the VOCs in breath as a robust source of candidate biomarkers. We also highlight key recent papers across select fields, critically reviewing the progress made in the past few years to advance breath research. VOCs are a set of metabolites that can be sampled in exhaled breath to act as advantageous biomarkers in a variety of clinical contexts.
      datePublished:2024-07-08T00:00:00Z
      dateModified:2024-07-08T00:00:00Z
      pageStart:1
      pageEnd:25
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s11306-024-02142-x
      keywords:
         Breath analysis
         Volatile organic compounds
         Breath biomarkers
         Breathomics
         Volatilomics
         Biochemistry
         general
         Molecular Medicine
         Cell Biology
         Developmental Biology
         Biomedicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-024-02142-x/MediaObjects/11306_2024_2142_Fig7_HTML.png
      isPartOf:
         name:Metabolomics
         issn:
            1573-3890
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hsuan Chou
            url:http://orcid.org/0000-0002-8028-225X
            affiliation:
                  name:Owlstone Medical Ltd.
                  address:
                     name:Owlstone Medical Ltd., Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lucy Godbeer
            affiliation:
                  name:Owlstone Medical Ltd.
                  address:
                     name:Owlstone Medical Ltd., Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Max Allsworth
            affiliation:
                  name:Owlstone Medical Ltd.
                  address:
                     name:Owlstone Medical Ltd., Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Billy Boyle
            affiliation:
                  name:Owlstone Medical Ltd.
                  address:
                     name:Owlstone Medical Ltd., Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Madeleine L. Ball
            url:http://orcid.org/0000-0002-6150-0485
            affiliation:
                  name:Owlstone Medical Ltd.
                  address:
                     name:Owlstone Medical Ltd., Cambridge, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Metabolomics
      issn:
         1573-3890
      volumeNumber:20
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Owlstone Medical Ltd.
      address:
         name:Owlstone Medical Ltd., Cambridge, UK
         type:PostalAddress
      name:Owlstone Medical Ltd.
      address:
         name:Owlstone Medical Ltd., Cambridge, UK
         type:PostalAddress
      name:Owlstone Medical Ltd.
      address:
         name:Owlstone Medical Ltd., Cambridge, UK
         type:PostalAddress
      name:Owlstone Medical Ltd.
      address:
         name:Owlstone Medical Ltd., Cambridge, UK
         type:PostalAddress
      name:Owlstone Medical Ltd.
      address:
         name:Owlstone Medical Ltd., Cambridge, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hsuan Chou
      url:http://orcid.org/0000-0002-8028-225X
      affiliation:
            name:Owlstone Medical Ltd.
            address:
               name:Owlstone Medical Ltd., Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Lucy Godbeer
      affiliation:
            name:Owlstone Medical Ltd.
            address:
               name:Owlstone Medical Ltd., Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Max Allsworth
      affiliation:
            name:Owlstone Medical Ltd.
            address:
               name:Owlstone Medical Ltd., Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Billy Boyle
      affiliation:
            name:Owlstone Medical Ltd.
            address:
               name:Owlstone Medical Ltd., Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Madeleine L. Ball
      url:http://orcid.org/0000-0002-6150-0485
      affiliation:
            name:Owlstone Medical Ltd.
            address:
               name:Owlstone Medical Ltd., Cambridge, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Owlstone Medical Ltd., Cambridge, UK
      name:Owlstone Medical Ltd., Cambridge, UK
      name:Owlstone Medical Ltd., Cambridge, UK
      name:Owlstone Medical Ltd., Cambridge, UK
      name:Owlstone Medical Ltd., Cambridge, UK

External Links {🔗}(828)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.45s.

LINK . SPRINGER . COM {}